✦ LIBER ✦

Energy and protein intake of and nutritional status in non-surgically treated patients with small cell anaplastic carcinoma of the lung

Book ID: 122679758
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 175 KB
Volume: 3
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(87)80483-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Significance of P53 and Rb protein expre

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers

✍ Yung-Chie Lee; Yih-Leong Chang; Shi-Ping Luh; Jang-Ming Lee; Jin-Shing Chen 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 334 KB

Relevance of ERCC1, RRM1 and BRCA1 in su

Relevance of ERCC1, RRM1 and BRCA1 in surgically treated non-small cell lung cancer patients

✍ Pesta, Martin; Topolcan, Ondrej; Kulda, Vlastimil; Fiala, Ondrej; Krakorova, Gab 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 69 KB

P-153 The prognostic value of altered pR

P-153 The prognostic value of altered pRb and p53 protein expression in surgically treated non-small cell lung cancer patients

✍ Jassem, J.; Dworakowska, D.; Jassem, E.; Dworakowski, R.; Wiedorn, K.; Boltze, C 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB

The nutritional status of patients with

The nutritional status of patients with small cell lung cancer before and during treatment with chemotherapy

✍ Hosker, HSR; Jones, GM; Corris, PA 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Long-Term survival of patients treated w

Long-Term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma

✍ Luigi Corti; Lamberto Toniolo; Caterina Boso; Flavio Colaut; Davide Fiore; Pier- 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

## Abstract ## Purpose The role of photodynamic therapy (PDT) in the treatment of small cancers has been established in several clinical studies. Here, we report on the efficacy of PDT for early inoperable or recurrent non‐small‐cell lung cancer (NSCLC). ## Methods and Materials From June 1989 t

Therapeutic efficacy and pharmacokinetic

Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma

✍ Joachim Z. Fuks; Merrill J. Egorin; Joseph Aisner; David A. Echo; Stanley Ostrow 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 480 KB

Twenty-nine patients with non-small cell lung cancer refractory to prior therapy were treated with either vindesine (VDS) alone (3 mg/m2 every week) or the combination of VDS plus cisplatin (DDP) (100 mg/m2 every 28 days). Serial blood and urine samples were collected to assess the pharmacokinetics